Oral Semaglutide Price in the UK: What Private Treatment Actually Costs

What the evidence says, and why it shapes what you pay

When the MHRA approved Wegovy tablets in June 2026, the published trial data gave a clear picture of what the medicine can do. In the OASIS 4 phase-3 trial (307 adults with obesity or overweight plus at least one weight-related condition, 64 weeks, versus placebo alongside lifestyle changes), participants lost an average of around 13.6% of their body weight. Among those who followed treatment fully throughout, the average reached roughly 16–17%. Those figures come from NHS clinical information on semaglutide and the Novo Nordisk approval announcement, they are the numbers a prescriber will discuss with you.

This evidence matters for cost because it explains why oral semaglutide is priced as a clinically serious intervention rather than a supplement. The titration schedule runs from 1.5mg to 4mg to 9mg and up to a 25mg maintenance dose, with at least a month at each level. That time-in-treatment means the genuine cost of a course runs across months, not a single transaction. Any price that seems to skip that clinical reality is worth questioning before you commit.

A question our prescribers hear most weeks: "Can I just buy a month's supply to try it?" The honest answer is that the titration schedule means the early weeks are adjustment weeks, not the full therapeutic picture, so a realistic cost comparison needs to account for the full supervised course, not a single entry-level pack. If you are looking specifically at the opening stage of treatment, our page on semaglutide 3mg tablet pricing explains what that first dose level costs and what it covers.

What headline prices usually leave out, and why it matters for oral semaglutide

Private weight-loss treatment is often advertised with a lead figure that covers the tablets alone. The fuller cost depends on what a provider bundles in. Common extras that may or may not be included: the initial medical consultation (sometimes charged separately at £25–£75), the prescription fee, any follow-up reviews at dose-increase points, delivery, and ongoing clinical support if side effects arise. For oral semaglutide specifically, the titration journey runs through four dose levels, which means multiple clinical reviews are part of responsible treatment, not optional add-ons.

Storage is also worth noting when you compare. Unlike the weekly injection, Wegovy tablets require no refrigeration. That makes them practical for travel and everyday life, but it does not reduce the clinical oversight required, a prescriber still reviews your progress before each stage. If you are weighing up the injection versus the tablet, our overview of semaglutide tablet treatment lays out the differences clearly, and the detailed cost breakdown for oral semaglutide covers the numbers by dose.

On the question of discount codes: nume does not run them, for prescription medicines or anything else. A promotional code attached to a prescription-only weight-loss medicine from an unverified seller is a genuine red flag, the MHRA's Yellow Card scheme exists partly to capture reports of suspect supply, and the regulator has issued repeated warnings about fake pens and tablets sold through social media and unofficial channels. Safe supply means a verified pharmacy you can check by name on the GPhC pharmacy register.

What nume's price includes, and why we are not the cheapest option

We price oral semaglutide to cover everything that responsible treatment requires: the prescriber's clinical review, the prescription, the tablets, next-working-day DPD delivery, and access to a clinical team seven days a week. There are no bolt-ons. Current treatment pricing is shown on our treatment and consultation page.

We lose the price comparison on purpose. The calculation we made when building this service was that a GPhC-registered pharmacy with same-day prescriber review, live weight verification on video, identity checks, and GP notification cannot also be the cheapest listing on a comparison site. Something has to give, and we chose not to let it be the clinical infrastructure. If you want to know more about the team behind those decisions, our clinical lead's profile is publicly available.

For those exploring the broader cost landscape across dose levels, our semaglutide tablet pricing guide covers how costs shift as treatment progresses, and the dedicated oral cost page addresses the most common pricing questions in more detail. It is also worth noting that oral semaglutide (Wegovy tablets) is a different medicine from Rybelsus, the oral semaglutide licensed for type 2 diabetes; the Rybelsus page explains the distinction for anyone who has seen those tablet strengths mentioned elsewhere.

The right question to ask is not 'cheapest', it is 'safest and most complete'

For a prescription medicine that requires titration over months, the cheapest listing answers the wrong question. The relevant questions are: does this provider include full prescriber review at each dose stage? Can I verify the pharmacy on the GPhC register? Is the supply chain licensed? Those are the measures that keep you safe, not the headline monthly figure.

Oral semaglutide's licensed eligibility covers adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related condition such as hypertension or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A prescriber assesses the full picture, BMI alone does not confirm suitability. If you are unsure where you stand, our weight-loss treatment overview covers the eligibility landscape, and our FAQs address the questions that come up most often before people start. The most direct next step is a free consultation: a clinician reads your answers the same day and gives you a clear answer. That is the cost-effective starting point, because it costs nothing and tells you exactly where you stand.